Sally I. Eissa
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
Papers in
-
- Synthesis and biological activity 11
- Quinazolinone synthesis and applications 4
- Synthesis and Biological Evaluation 4
- Synthesis and Characterization of Heterocyclic Compounds 2
-
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Yousry A. Ammar (7 shared papers)Mohamed Ayman El‐Zahabi (5 shared papers)Hazem Elkady (4 shared papers)Amel M. Farrag (5 shared papers)Ahmed B. M. Mehany (3 shared papers)Abdallah E. Abdallah (3 shared papers)Helmy Sakr (3 shared papers)Eman A. Fayed (2 shared papers)
- Journals
- Bioorganic Chemistry (4 papers)Medicinal Chemistry Research (3 papers)Molecular Diversity (1 paper)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)New Journal of Chemistry (1 paper)
- Partner nations
- EgyptSaudi ArabiaIndonesia
In The Last Decade
Sally I. Eissa
16 papers receiving 620 citations
Peers
Comparison fields: 5 of 56
- Toxicology 76
- Organic Chemistry 452
- Molecular Biology 251
- Hematology 32
- Oncology 75
Countries citing papers authored by Sally I. Eissa
This map shows the geographic impact of Sally I. Eissa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally I. Eissa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally I. Eissa more than expected).
Fields of papers citing papers by Sally I. Eissa
This network shows the impact of papers produced by Sally I. Eissa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally I. Eissa. The network helps show where Sally I. Eissa may publish in the future.
Co-authors
The 25 scholars most cited alongside Sally I. Eissa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 94 | |
| 2 | 2021 | 93 | |
| 3 | 2015 | 77 | |
| 4 | 2021 | 60 | |
| 5 | 2021 | 59 | |
| 6 | 2021 | 56 | |
| 7 | 2022 | 51 | |
| 8 | 2018 | 39 | |
| 9 | 2023 | 29 | |
| 10 | 2018 | 22 | |
| 11 | 2023 | 20 | |
| 12 | 2020 | 11 | |
| 13 | 2014 | 8 | |
| 14 | 2025 | 5 | |
| 15 | 2017 | 3 | |
| 16 | 2017 | 2 |
About Sally I. Eissa
Sally I. Eissa is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Hematology and Toxicology, having authored 16 papers that have together received 629 indexed citations. Recurring topics across this work include Synthesis and biological activity (11 papers), Quinazolinone synthesis and applications (4 papers), Synthesis and Biological Evaluation (4 papers), Cancer therapeutics and mechanisms (3 papers), Multiple Myeloma Research and Treatments (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Protein Degradation and Inhibitors (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Toxicology (76 citations), Organic Chemistry (452 citations), Molecular Biology (251 citations), Hematology (32 citations) and Oncology (75 citations). Sally I. Eissa has collaborated with scholars based in Egypt, Saudi Arabia and Indonesia. Frequent co-authors include Yousry A. Ammar, Mohamed Ayman El‐Zahabi, Hazem Elkady, Amel M. Farrag, Ahmed B. M. Mehany, Abdallah E. Abdallah, Helmy Sakr, Eman A. Fayed, Khaled El‐Adl and Ibrahim H. Eissa. Their work appears in journals such as Bioorganic Chemistry, Medicinal Chemistry Research, Molecular Diversity, Journal of Enzyme Inhibition and Medicinal Chemistry and New Journal of Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.